Source: Chemical Biology and Drug Design. Unidade: EACH
Subjects: DIABETES MELLITUS, DIABETES MELLITUS, INIBIDORES DE ENZIMAS, MEDICAMENTO
ABNT
PAULA, Heberth de et al. Semisynthetic p-coumaric acid derivatives as leadDual inhibitors against DPP-IV and GSK-3β for antidiabetic therapy. Chemical Biology and Drug Design, v. No 2024, n. 5, p. 01-15, 2024Tradução . . Disponível em: http://dx.doi.org/10.1111/cbdd.70016. Acesso em: 07 out. 2025.APA
Paula, H. de, Bolsoni, C. S., Souza, F. F. de, Fonseca, V. da R., Romão, W., Sairre, M. I. de, et al. (2024). Semisynthetic p-coumaric acid derivatives as leadDual inhibitors against DPP-IV and GSK-3β for antidiabetic therapy. Chemical Biology and Drug Design, No 2024( 5), 01-15. doi:10.1111/cbdd.70016NLM
Paula H de, Bolsoni CS, Souza FF de, Fonseca V da R, Romão W, Sairre MI de, Honorio KM, Lacerda Jr. V, Morais PAB. Semisynthetic p-coumaric acid derivatives as leadDual inhibitors against DPP-IV and GSK-3β for antidiabetic therapy [Internet]. Chemical Biology and Drug Design. 2024 ; No 2024( 5): 01-15.[citado 2025 out. 07 ] Available from: http://dx.doi.org/10.1111/cbdd.70016Vancouver
Paula H de, Bolsoni CS, Souza FF de, Fonseca V da R, Romão W, Sairre MI de, Honorio KM, Lacerda Jr. V, Morais PAB. Semisynthetic p-coumaric acid derivatives as leadDual inhibitors against DPP-IV and GSK-3β for antidiabetic therapy [Internet]. Chemical Biology and Drug Design. 2024 ; No 2024( 5): 01-15.[citado 2025 out. 07 ] Available from: http://dx.doi.org/10.1111/cbdd.70016